In use product safety assessment report for Zalviso® (sufentanil citrate) sublingual tablets

A UKMi Product Safety assessment on Zalviso® (sufentanil citrate) sublingual tablets which describes the in-use medication safety considerations resultant from the product’s presentation or other pre-defined characteristics. Potential next steps and mitigation actions are suggested.

UKMi Product Safety assessments are produced using the validated UKMi product assessment tool.

Acute CareAnaesthesia and painMedicines SafetySurgery

Attachments